0001104659-20-122047.txt : 20201105 0001104659-20-122047.hdr.sgml : 20201105 20201105212603 ACCESSION NUMBER: 0001104659-20-122047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201103 FILED AS OF DATE: 20201105 DATE AS OF CHANGE: 20201105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stoneman Sandra G. CENTRAL INDEX KEY: 0001831144 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39580 FILM NUMBER: 201292217 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE, SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immunome Inc. CENTRAL INDEX KEY: 0001472012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770694340 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 610-321-3700 MAIL ADDRESS: STREET 1: 665 STOCKTON DRIVE STREET 2: SUITE 300 CITY: EXTON STATE: PA ZIP: 19341 4 1 a4.xml 4 X0306 4 2020-11-03 0 0001472012 Immunome Inc. IMNM 0001831144 Stoneman Sandra G. C/O IMMUNOME, INC. 665 STOCKTON DRIVE, SUITE 300 EXTON PA 19341 0 1 0 0 Chief Legal Officer & Gen Coun Employee Stock Option (Right to Buy) 11.38 2020-11-03 4 A 0 148837 0 A 2030-11-03 Common Stock 148837 148837 D Twenty-five percent (25%) of the shares subject to the option shall vest on October 26, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter. /s/ Sandra G. Stoneman 2020-11-05